Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

CSSIFM Clinical Trials
As part of our mission to deliver the latest medical breakthroughs, CSSIFM medical providers conduct clinical trials that test new treatments for a wide range of patients and cancer types. The following trials are being conducted at CSSIFM and new ones are on the horizon.

Please fill out the Clinical Trial Inquiry form at the below link for more information.
Slide 1
Block
NK Cells
What are Natural Killer Cells (NK cells)?

The immune system is a collection of diverse cells, each with a distinct role in protecting us from infections and diseases. Among these are the natural killer (NK) cells, the body’s first line of defense. As part of the ‘innate’ immune response, NK cells have the ability to recognize and destroy abnormal (such as cancerous or virally-infected) cells and are uniquely powerful. They are always activated and ready to eliminate diseased cells without delay. We harness this power with our activated natural killer (aNK) platform based upon NK cells from a distinct cell line.
 
To further leverage the power of innate immune responses, we have developed a proprietary IL-15 superagonist, Anktiva® (N-803), which selectively activates NK cells and T effector cells, without activating regulatory T cells that may dampen responses. These platforms can be combined for clinical synergy in patients and such combination has produced complete responses in difficult-to-treat cancers, such as Merkel Cell Carcinoma (MCC), advanced pancreatic cancer, and advanced triple negative breast cancer (TNBC).

Patients

Our goal is to provide patients with the highest level of expertise, as well as continuity of care.

Find a Clinical Trial

CSSIFM medical providers conduct clinical trials that test new treatments for a wide range of patients and cancer types.

Patients

Our immune-oncology drugs, access to clinical trials, and partnerships with leading research institutions.

Find a Clincial Trial

Our immune-oncology drugs, access to clinical trials, and partnerships with leading research institutions.

Block
CSSIFM Clinical Trial Inquiry

State-of-the-art diagnosis and
treatment options for cancer patients

Patients

Our immune-oncology drugs, access to clinical trials, and partnerships with leading research institutions.

Find a Clincial Trial

Our immune-oncology drugs, access to clinical trials, and partnerships with leading research institutions.

Please complete the form on this page to connect with a CSSIFM research site and start your clinical trial journey

Oncologist
Tara E. Seery, MD
Fill out my online form.

After you submit your info, a CSSIFM staff member will review your info. They will contact you to discuss available clinical trials and/or treatment options.
 
Depending on the trial, health insurance may be required.
 
Remember, there is never an obligation to join — we're here to help you make the best decision.

Block
Chan Soon-Shiong Institute for Medicine
CSSIFM logo

State-of-the-art diagnosis and treatment options for cancer patients

Contact Us

2040 East Mariposa Avenue
El Segundo, California 90245

Phone: 213-266-5600
Fax: 562-548-2304

Request an Appointment

1-855-797-9277

For additional information on CSSIFM, please email us here.

Patients

Our immune-oncology drugs, access to clinical trials, and partnerships with leading research institutions.

Find a Clincial Trial

Our immune-oncology drugs, access to clinical trials, and partnerships with leading research institutions.